NAV11/16/2017 Chg.+7.9300 Type of yield Investment Focus Investment company
503.8800EUR +1.60% reinvestment Equity Worldwide Bellevue Asset Mgmt. 

Monthly performance

  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total
2009 - - - - -2.57 6.12 6.42 -1.06 3.16 -11.73 4.92 5.03 -
2010 4.64 4.78 5.80 0.08 -5.05 -3.26 -3.14 0.42 4.28 4.50 1.74 4.27 +19.88%
2011 -5.00 -0.58 -1.77 3.43 3.21 -1.63 -1.22 -13.48 -0.20 1.92 4.02 6.76 -5.94%
2012 12.44 -0.50 3.77 0.96 6.42 1.08 6.96 -0.39 3.53 -9.25 4.57 -1.92 +29.46%
2013 4.41 5.53 9.71 6.48 4.70 -4.20 12.28 -2.09 6.27 -3.63 8.04 -0.23 +56.68%
2014 12.36 4.08 -10.71 -4.63 4.48 8.14 1.15 13.08 3.01 11.02 3.10 2.31 +55.24%
2015 15.70 6.35 4.96 -7.88 12.24 -2.01 2.87 -12.82 -12.03 10.61 7.05 -1.90 +19.90%
2016 -22.80 -5.60 -0.37 3.47 6.31 -9.21 12.44 -2.44 1.99 -11.88 12.34 -3.40 -22.44%
2017 4.88 9.03 -1.17 -0.11 -6.90 5.94 -0.60 3.74 -0.40 -4.51 -1.20 - -

Calculated values

  YTD 6 Months 1 Year 3 Years 5 Years
Volatility 18.83% 19.19% 19.48% 29.45% 27.19%
Sharpe ratio 0.50 -0.24 0.03 0.10 0.74
Best month +9.03% +5.94% +12.34% +15.70% +15.70%
Worst month -6.90% -6.90% -6.90% -22.80% -22.80%
Maximum loss -11.01% -11.01% -11.01% -44.38% -44.38%
Outperformance -3.97% - -4.58% -8.36% -9.30%
 
All quotes in EUR

Tranches

Name   Type of yield Repurchase p. 1 Year 3 Years
BB Adamant Biotech I USD reinvestment 473.9300 +11.40% +4.31%
BB Adamant Biotech I EUR reinvestment 539.1700 +1.01% +10.37%
BB Adamant Biotech I CHF reinvestment 414.9200 +10.10% +7.42%
BB Adamant Biotech I GBP reinvestment 379.5900 +4.87% -
BB Adamant Biotech B USD reinvestment 444.5400 +10.58% +2.02%
BB Adamant Biotech B CHF reinvestment 387.1000 +9.30% +5.07%
BB Adamant Biotech B EUR reinvestment 503.8800 +0.27% +7.95%

Performance

YTD  
+7.89%
6 Months
  -2.53%
1 Year  
+0.27%
3 Years  
+7.95%
5 Years  
+146.17%
Since start  
+303.10%
Year
2016
  -22.44%
2015  
+19.90%
2014  
+55.24%
2013  
+56.68%
2012  
+29.46%
2011
  -5.94%
2010  
+19.88%